Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$209.01 - $232.56 $1,045 - $1,162
-5 Reduced 0.11%
4,657 $1.02 Million
Q4 2023

Feb 13, 2024

BUY
$197.69 - $227.29 $7,512 - $8,637
38 Added 0.82%
4,662 $1.06 Million
Q1 2023

May 12, 2023

BUY
$213.32 - $257.83 $2,133 - $2,578
10 Added 0.22%
4,624 $1.06 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $25,601 - $32,773
-125 Reduced 2.64%
4,614 $945,000
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $3,207 - $4,168
-15 Reduced 0.32%
4,739 $1.11 Million
Q4 2021

Feb 09, 2022

SELL
$271.6 - $314.21 $9,506 - $10,997
-35 Reduced 0.73%
4,754 $1.49 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $34,352 - $38,542
125 Added 2.68%
4,789 $1.35 Million
Q1 2021

May 11, 2021

BUY
$204.88 - $255.03 $62,693 - $78,039
306 Added 7.02%
4,664 $1.19 Million
Q4 2020

Feb 05, 2021

SELL
$186.91 - $214.42 $22,989 - $26,373
-123 Reduced 2.74%
4,358 $887,000
Q1 2020

May 13, 2020

BUY
$104.32 - $195.28 $43,292 - $81,041
415 Added 10.21%
4,481 $566,000
Q3 2019

Nov 01, 2019

SELL
$159.77 - $178.1 $121,584 - $135,534
-761 Reduced 15.77%
4,066 $683,000
Q2 2019

Aug 02, 2019

BUY
$144.16 - $172.9 $10,812 - $12,967
75 Added 1.58%
4,827 $835,000
Q1 2019

May 20, 2019

BUY
$123.7 - $156.3 $3,216 - $4,063
26 Added 0.55%
4,752 $727,000
Q4 2018

Feb 13, 2019

SELL
$120.82 - $174.09 $17,639 - $25,417
-146 Reduced 3.0%
4,726 $597,000
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $12,575 - $14,120
75 Added 1.56%
4,872 $846,000
Q1 2018

May 10, 2018

BUY
$161.53 - $178.11 $40,705 - $44,883
252 Added 5.54%
4,797 $776,000
Q4 2017

Feb 13, 2018

SELL
$147.99 - $163.95 $12,431 - $13,771
-84 Reduced 1.81%
4,545 $725,000
Q3 2017

Nov 09, 2017

BUY
$149.47 - $160.56 $691,896 - $743,232
4,629
4,629 $699,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Holderness Investments CO Portfolio

Follow Holderness Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holderness Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Holderness Investments CO with notifications on news.